SARS-CoV-2 Infection

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, SARS-CoV-2 Infection, Coronavirus Infection Trial in United States (TXA127, TRV027, Placebo)

Recruiting
  • COVID-19
  • +2 more
  • Birmingham, Alabama
  • +68 more
Jan 24, 2023

SARS-CoV-2 Infection Trial in United States (Moderna COVID-19 Vaccine)

Completed
  • SARS-CoV-2 Infection
  • Moderna COVID-19 Vaccine
  • Birmingham, Alabama
  • +50 more
Dec 1, 2022

COVID-19, SARS-CoV-2 Infection Trial in United States (NVX-Cov2373)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 Infection
  • Long Beach, California
  • +30 more
Jul 18, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (BNT162b2, Placebo, BNT162b2 OMI)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • +4 more
  • Athens, Alabama
  • +158 more
Jul 18, 2022

Pneumococcal Disease, COVID-19, SARS-CoV-2 Infection Trial in United States (20-valent pneumococcal conjugate vaccine (20vPnC),

Completed
  • Pneumococcal Disease
  • +2 more
  • 20-valent pneumococcal conjugate vaccine (20vPnC)
  • +2 more
  • Anaheim, California
  • +28 more
Mar 23, 2022

Covid19, SARS-CoV-2 Infection Trial in Iowa City, Saint Louis (GC4419, Placebo)

Terminated
  • Covid19
  • SARS-CoV-2 Infection
  • Iowa City, Iowa
  • +2 more
Mar 14, 2022

Covid19, Anosmia, Olfactory Disorder Trial in Saint Louis (Theophylline Powder)

Completed
  • Covid19
  • +7 more
  • Theophylline Powder
  • Saint Louis, Missouri
    Washington University School of Medicine in Saint Louis
Feb 1, 2022

Anosmia, Covid19, Ageusia Trial in Saint Louis (Smell Training)

Active, not recruiting
  • Anosmia
  • +6 more
  • Smell Training
  • Saint Louis, Missouri
    Washington University School of Medicine in Saint Louis
Apr 2, 2021